An automated text messaging system increases patient engagement with home-based exercise and promotes faster recovery after total knee or hip replacement surgery, reports a study in the January 16, 2019 issue of The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer. Patients receiving timely […]Continue Reading ...
WEDNESDAY, Jan. 16, 2019 — For relapsing-remitting multiple sclerosis (MS), the risk for conversion to secondary progressive MS is lower with initial treatment with fingolimod, alemtuzumab, or natalizumab versus glatiramer acetate or interferon beta, according to a study published online in the Jan. 15 issue of the Journal of the American Medical Association. J. William […]Continue Reading ...
Opioid drugs prescribed to children for pain relief after a typical pediatric orthopaedic procedure may be significantly overprescribed, according to a new study by researchers at Children’s Hospital of Philadelphia (CHOP). The patients used less than 25 percent of the drugs, suggesting a potential risk of opioid diversion. The findings were published on Jan. 16, […]Continue Reading ...
A new report published today in JAMA Oncology describes alarmingly high rates of undiagnosed acute and chronic hepatitis B and hepatitis C in patients with cancer. These diseases could be seriously detrimental to treatment outcomes. vitstudio | Shutterstock Hepatitis B and hepatitis C are serious but treatable viral infections, which can have life-threatening complications. These […]Continue Reading ...
Patients with relapsing multiple sclerosis (MS) have benefited from an experimental stem cell therapy. MS is an autoimmune disease where the central nervous system is affected. It is severely debilitating and means a slow and progressive death for the patients. A new study titled, ‘Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy […]Continue Reading ...
Schizophrenia is a serious, chronic mental disorder involving a series of symptoms. It is one of the leading causes of disability worldwide. Various symptoms of this disorder, such as delusions and hallucinations, have been shown to be very adequately treated by means of antipsychotics, and its symptomatology can be improved. Yet patients experience many difficulties […]Continue Reading ...
ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in the U.S.1 “This […]Continue Reading ...
People with cancer are more than four times more likely to commit suicide than people without cancer, according to Penn State College of Medicine researchers. In a study using data on more than eight million cancer patients in the United States, the researchers also found that among people with cancer, white males; patients who were […]Continue Reading ...
A new nuclear medicine method for detecting malignant melanoma, one of the most aggressive skin cancers, has been successfully tested for the first time in humans and could improve detection of both primary and metastatic melanoma. The research is featured in the January 2019 print issue of the Journal of Nuclear Medicine. The National Cancer […]Continue Reading ...
A multicenter study from SWOG Cancer Research Network found that infections with hepatitis B and C are common in new cancer patients, but few of these patients are screened for the viruses.Continue Reading ...
The UPV/EHU-University of the Basque Country is proposing improvements with respect to the pharmacological study of cognitive function enhancers in patients with schizophrenia A study by the UPV/EHU has assessed the effectiveness of various drugs, which are used to delay cognitive deterioration in patients with Alzheimer’s, in improving cognitive impairment displayed by patients with schizophrenia. […]Continue Reading ...
[protected-iframe id=”66513ec5938d49b4a4221283149c9496-7618883-121704370″ info=”https://www.npr.org/player/embed/633979867/680559527″ width=”100%” height=”290″ frameborder=”0″ scrolling=”no”]Tammy Fox wanted to help after a friend took ill with a rare and difficult-to-diagnose autoimmune disorder that required many trips to the Mayo Clinic. Although Fox couldn’t do anything medically, she knew there was a way to ease some of the burden of medical bills and costs associated […]Continue Reading ...
BOULDER, Colo., Jan. 10, 2019 (GLOBE NEWSWIRE) — miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced data from its Phase 1 clinical trial evaluating the safety, tolerability and efficacy of cobomarsen, an inhibitor of microRNA-155, in cutaneous T-cell lymphoma (CTCL) and in adult […]Continue Reading ...
While the Trump administration decides whether to adopt a controversial policy that could jeopardize the legal status of immigrants who use public programs such as Medicaid, doctors and clinics are torn between informing patients about the potential risks and unnecessarily scaring them into dropping their coverage or avoiding care. “We are walking a fine line,” […]Continue Reading ...
A pilot scheme called the HIP QIP programme was implemented across six trusts. Five of these were in England and one in Scotland. The scheme involves giving the elderly patients with hip fractures one extra meal per day. Results showed that this strategy can reduce the deaths among these patients by half. The pilot scheme […]Continue Reading ...
- 4.6 percent of Massachusetts residents have opioid use disorder
- New study suggests vital exhaustion as risk factor for dementia
- New antibiotic discovery heralds breakthrough in the fight against drug-resistant bacteria
- Ural Federal University scientists synthesize a group of multi-purpose fluorophores
- Researchers identify new therapeutic target in the fight against chronic liver diseases
- Preparation, characterization of Soyasapogenol B loaded onto functionalized MWCNTs
- FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin
- Tobacco use linked with higher use of opioids and sedatives
- Study delves deeper into developmental dyslexia
- Anti-vaccination movement one of the top health threats in 2019 says WHO
- Newly developed risk score more effective at identifying type 1 diabetes
- Highly effective protocol to prepare cannabis samples for THC/CBD analysis
- Prinston Pharmaceutical Inc. Issues Voluntary Nationwide Recall of Irbesartan and Irbesartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodiethylamine (NDEA) in the Products
- How does solid stress from brain tumors cause neuronal loss, neurologic dysfunction?
- $14.7 million partnership to supercharge vaccine development
- Ian Fotheringham receives Charles Tennant Memorial Lecture award
- Brain vital signs detect neurophysiological impairments in players with concussions
- Lack of job and poor housing conditions increased likelihood of people attending A&E
- Novel targeted drug delivery system improves conventional cancer treatments
- Rutgers study finds gene responsible for spread of prostate cancer